首页 | 本学科首页   官方微博 | 高级检索  
     


Low Dose of Bisphosphonate Enhances Sclerostin Antibody‐Induced Trabecular Bone Mass Gains in Brtl/+ Osteogenesis Imperfecta Mouse Model
Authors:Diana Olvera  Rachel Stolzenfeld  Joan C Marini  Michelle S Caird  Kenneth M Kozloff
Affiliation:1. Department of Orthopaedic Surgery, University of Michigan, Ann Arbor, MI, USA;2. Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI, USA;3. Bone and Extracellular Matrix Branch, National Institute of Child Health and Human Disorders, National Institutes of Health, Bethesda, MD, USA
Abstract:
Keywords:OSTEOGENESIS IMPERFECTA  ANABOLICS  SCLEROSTIN ANTIBODY  BISPHOSPHONATE  PRECLINICAL STUDIES
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号